Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384 –390

We read the article by Bezin et  al. (1) with interest and would like to point out several flaws that make the interpretation unreliable.
Source: Diabetes Care - Category: Endocrinology Source Type: research